PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Clinical trials for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME trials appear
Sign up with your email to follow new studies for PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for kids with sudden OCD and tics?
Symptom relief CompletedThis study tested a medicine called Panzyga (an immunoglobulin) against a placebo in 71 children aged 6 to 17 with PANS/PANDAS, a condition causing sudden severe OCD and other symptoms. The main goal was to see if Panzyga reduced OCD symptoms more than placebo after 9 weeks. Rese…
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Phase: PHASE3 • Sponsor: Octapharma • Aim: Symptom relief
Last updated May 26, 2026 06:16 UTC
-
New study reveals hidden costs of treating PANS with IVIG
Knowledge-focused CompletedThis study surveyed 65 families to understand the economic and quality-of-life impact of IVIG treatment for children with PANS or PANDAS. Researchers asked about medical visits, insurance coverage, work and school attendance, and emotional well-being. The goal is to better descri…
Matched conditions: PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated May 26, 2026 06:30 UTC